Pharvaris (PHVS) Exchange Rate Effect (2020 - 2026)
Pharvaris (PHVS) posted Exchange Rate Effect of $4.9 million for Q1 2026, up 5398.82% on a QoQ basis from $88541.8 in Q4 2025, and up 183.79% year-over-year from $1.7 million in Q1 2025.
Pharvaris (PHVS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Pharvaris' Exchange Rate Effect history runs 7 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- Quarterly Exchange Rate Effect rose 183.79% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 306.13% YoY) and the FY2025 annual result came in at -$14.0 million, down 273.11% from the prior year.
- Exchange Rate Effect was $4.9 million for Q1 2026 at Pharvaris, up from $88541.8 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $752.6 billion in Q3 2023 and bottomed at -$752.8 billion in Q2 2023.
- A 5-year average of -$13.1 million and a median of $88541.8 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 6439040.72% in 2023, while the deepest fall reached 6196390.97% in 2023.
- Pharvaris' Exchange Rate Effect stood at -$15.6 million in 2022, then jumped by 65.38% to -$5.4 million in 2023, then soared by 299.46% to $10.8 million in 2024, then plunged by 99.18% to $88541.8 in 2025, then soared by 5398.82% to $4.9 million in 2026.
- Business Quant data shows PHVS's Exchange Rate Effect at $4.9 million in Q1 2026, $88541.8 in Q4 2025, and -$37999.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | 4.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.87 Mn |
| Mar 31, 2026 | 4.87 Mn |
| Dec 31, 2025 | 88,541.81 |
| Dec 31, 2025 | 88,541.81 |
| Sep 30, 2025 | -37,998.97 |
| Sep 30, 2025 | -37,998.97 |
| Jun 30, 2025 | -7.85 Mn |
| Jun 30, 2025 | -7.85 Mn |
| Mar 31, 2025 | -5.81 Mn |
| Mar 31, 2025 | -5.81 Mn |
| Dec 31, 2024 | 10.78 Mn |
| Dec 31, 2024 | 10.78 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 627,925.79 |
| Mar 31, 2024 | 627,925.79 |
| Dec 31, 2023 | -5.40 Mn |
| Dec 31, 2023 | -5.40 Mn |